SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 504.38 |
| Enterprise Value ($M) | 298.20 |
| Book Value ($M) | 599.50 |
| Book Value / Share | 7.14 |
| Price / Book | 0.84 |
| NCAV ($M) | 484.76 |
| NCAV / Share | 5.78 |
| Price / NCAV | 1.04 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.30 |
| Return on Assets (ROA) | -0.32 |
| Return on Equity (ROE) | -0.39 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 17.24 |
| Current Ratio | 17.24 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 637.95 |
| Assets | 752.69 |
| Liabilities | 153.19 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 11.76 |
| Operating Income | -223.12 |
| Net Income | -200.07 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -149.55 |
| Cash from Investing | 27.69 |
| Cash from Financing | 212.58 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Vanguard Group Inc | 6.81 | 43.54 | |
| 13G/A | ARK Investment Management LLC | 8.74 | 60.91 | |
| 13G | BlackRock Inc. | 5.60 | ||
| 13G/A | State Street Corp | 4.81 | -13.52 | |
| 13G/A | Gv 2017, L.p. | 15.40 | 17.06 | |
| 13G/A | Fmr Llc | 4.84 | -44.92 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 252,981 | 1,377,097 | 18.37 | |
| 180,848 | 427,964 | 42.26 | |
| 128,798 | 416,230 | 30.94 | |
| 144,855 | 353,448 | 40.98 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| TYRA – Tyra Biosciences, Inc. | UBX – Unity Biotechnology, Inc. |
| UTHR – United Therapeutics Corporation | VIGL – Vigil Neuroscience, Inc. |
| VIR – Vir Biotechnology, Inc. |
Financial data and stock pages provided by
Fintel.io